PFE Stock Recent News
PFE LATEST HEADLINES
Dividend stocks are a favorite among investors for good reason. They provide a steady income stream of passive income and offer a promising avenue for total return.
Pharmaceutical giant Pfizer (PFE 1.29%) is trading near its lowest price in over a decade.
In the most recent trading session, Pfizer (PFE) closed at $26.64, indicating a +1.29% shift from the previous trading day.
Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and Goliath dynamic” in 2024, report says.
You've probably heard this before: Pharmaceutical stocks can bring an element of safety to your portfolio. Why is this the case?
The "RIG" portfolio aims for 50% income from defensive sectors and includes 83 stocks across 11+ sectors, focusing on investment-grade stocks. Defensive sectors include consumer staples, healthcare, utilities, and communication/telecom, with top-yield stocks like British American Tobacco and Pfizer. Groups 2 and 3 include defensive financials, bonds, ETFs, and preferred shares, contributing to stable income and meeting the 50% income goal.
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Pfizer CEO Albert Bourla joins CNBC's 'Special Report' as President-elect Donald Trump is inaugurated as the 47th U.S. president, becoming the second to serve two non-consecutive terms.
What would it take to make over $3,000 this year with only barely lifting a finger? My answer is having $50,000 and spending five minutes or so using an online brokerage.
In the world of speculative investments like meme coins, the "Greater Fool Theory" thrives. While some see huge profits, I prefer the stability of dividend stocks for steady growth. While others chase speculative investments, I remain firmly focused on dividend stocks, a strategy based on real value and tangible cash returns, not fleeting trends. The stocks I discuss offer impressive yields and solid growth potential, providing income-focused investors with consistent and reliable returns over the long term.